Moody's: Outlook for global healthcare industry stable for 2018

Moody's Investors Service's outlook for the global healthcare industry next year is stable.

Here are four things to know.

1. Moody's Investors Service's outlook is stable across three subsectors: pharmaceuticals, U.S. for-profit hospitals and U.S. medical products and devices.

2. The ratings agency anticipates earnings will grow between 1 and 2 percent due to successful product launches in oncology and other complex diseases. Aging populations will continue to fuel growing demand for pharmaceuticals.

3. U.S. for-profit hospitals will witness EBITDA growth of between 2.5 and 3 percent in 2018. However, as patients increasingly move to lower-cost settings, inpatient volumes will be constrained and rising labor and other expenses will pressure margins.

4. For U.S. medical products and devicemakers, Moody's Investors Service's predicts EBITDA growth of 3 to 3.5 percent. Growth will reflect new products, large mergers and acquisitions, and an aging population.

More articles on healthcare finance:
10 grants, donations to healthcare organizations in November
10 recent hospital, health system outlook and credit rating actions
Jackson Health System posts a profit for 6th consecutive year

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months